World Model · podcast knowledge graph

664. Are Thousands of Medical Cures Hiding in Plain Sight?

2026-02-20 · 52 min · episode 664 · 6 entities

episode page audio

Asserted relationships

  • → discusses Society & Culture concept
    0.40
    evidence rules-v4
    Feed category: Society & Culture
  • → hosted by Freakonomics Radio + Stitcher company
    0.40
    evidence rules-v4
    Feed author/publisher: Freakonomics Radio + Stitcher
  • → discusses Documentary concept
    0.40
    evidence rules-v4
    Feed category: Documentary

Entities found in this episode

concepts 4

  • mentioned Society & Culture concept
    0.50
    evidence rules-v4
    Feed category: Society & Culture
  • mentioned Documentary concept
    0.50
    evidence rules-v4
    Feed category: Documentary
  • discusses Society & Culture concept
    0.40
    evidence rules-v4
    Feed category: Society & Culture
  • discusses Documentary concept
    0.40
    evidence rules-v4
    Feed category: Documentary

companys 2

Episode description as stored
Existing drugs can sometimes be repurposed to treat rare diseases. But making that match can be hard — and the financial incentives are weak. Guest host Steve Levitt tries to solve the puzzle.   SOURCES: Chris Snyder , professor of economics at Dartmouth College. David Fajgenbaum , co-founder and president of Every Cure, physician-scientist at the University of Pennsylvania. Heather Stone , health science policy analyst at the Food & Drug Administration. Sarrin Chethik , senior policy analyst at the Market Shaping Accelerator.   RESOURCES: Chasing My Cure: A Doctor's Race to Turn Hope into Action; A Memoir , by David Fajgenbaum (2019). Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases , by Michael Kremer and Rachel Glennerster (2016). Market Shaping Accelerator . CURE ID Registry . Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.